Cofactor Genomics
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Cofactor Genomics is currently valued at N/A as of December 15, 2025. The company has raised a total of $28.7M in funding.
Investment Perspective
Cofactor Genomics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Cofactor Genomics Worth in 2025?
As of 2025, Cofactor Genomics is valued at N/A, based on the company's Later Stage VC funding round in December 15, 2025. This valuation positions Cofactor Genomics as one of the leading private companies in the sector.
Cofactor Genomics Valuation History
Cofactor Genomics's funding history demonstrates steady growth and investor confidence.
How Cofactor Genomics Valuation is Determined
Private company valuations like Cofactor Genomics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Cofactor Genomics Valuation FAQs
Is Cofactor Genomics profitable?
Cofactor Genomics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Cofactor Genomics's valuation compare to competitors?
Cofactor Genomics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Cofactor Genomics IPO?
Cofactor Genomics has not announced plans for an initial public offering. Until an IPO, investors can access Cofactor Genomics shares through secondary market platforms.